170 related articles for article (PubMed ID: 10514288)
1. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics.
Amblard M; Daffix I; Bergé G; Calmès M; Dodey P; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Martinez J
J Med Chem; 1999 Oct; 42(20):4193-201. PubMed ID: 10514289
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
Amblard M; Bedos P; Olivier C; Daffix I; Luccarini JM; Dodey P; Pruneau D; Paquet JL; Martinez J
J Med Chem; 2000 Jun; 43(12):2382-6. PubMed ID: 10882364
[TBL] [Abstract][Full Text] [Related]
4. A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist.
Bedos P; Amblard M; Subra G; Dodey P; Luccarini JM; Paquet JL; Pruneau D; Aumelas A; Martinez J
J Med Chem; 2000 Jun; 43(12):2387-94. PubMed ID: 10882365
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
[TBL] [Abstract][Full Text] [Related]
6. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
7. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells.
Yang CM; Tsai YJ; Pan SL; Wu WB; Wang CC; Lee YS; Lin CC; Huang SC; Chiu CT
Cell Signal; 1999 Dec; 11(12):853-62. PubMed ID: 10659993
[TBL] [Abstract][Full Text] [Related]
9. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
10. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
11. Characterization of bradykinin receptors in a human osteoblastic cell line.
Brechter AB; Lerner UH
Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
14. Ala scan analogues of HOE 140. Synthesis and biological activities.
Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea PA; Maggi CA; Regoli D
Eur J Med Chem; 2000 Nov; 35(11):1001-10. PubMed ID: 11137228
[TBL] [Abstract][Full Text] [Related]
15. The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold.
Dziadulewicz EK; Brown MC; Dunstan AR; Lee W; Said NB; Garratt PJ
Bioorg Med Chem Lett; 1999 Feb; 9(3):463-8. PubMed ID: 10091703
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens.
Scott P; Razzaque Z; Longmore J
Eur J Pharmacol; 2003 Jan; 458(3):319-25. PubMed ID: 12504789
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
18. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
Wall TM; Linseman DA; Hartman JC
Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
[TBL] [Abstract][Full Text] [Related]
19. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P
J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712
[TBL] [Abstract][Full Text] [Related]
20. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
